Shares of KeyCorp KEY slid 1.19% to $15.80 Tuesday, on what proved to be an all-around mixed trading session for the stock ...
The stock's rise snapped a three-day losing streak.
American Healthcare REIT (NYSE:AHR – Get Free Report) had its price objective cut by equities researchers at KeyCorp from $35 ...
KeyCorp (NYSE:KEY – Free Report) had its price target reduced by Wells Fargo & Company from $22.00 to $20.00 in a research ...
Scotiabank's $2.8B investment helped KeyCorp's 2024 strategy, driving net income growth, stronger capital ratios, and a 5.3% dividend yield. Click for more on KEY.
In the assessment of 12-month price targets, analysts unveil insights for KeyCorp, presenting an average target of $19.81, a high estimate of $22.00, and a low estimate of $18.00. Observing a downward ...
Wells Fargo analyst Mike Mayo lowered the firm’s price target on KeyCorp (KEY) to $20 from $22 and keeps an Overweight rating on the shares as ...
That bonus and the others related to the Scotiabank deal are based on target awards and scheduled to vest in two years, or ...
US banks' commercial and industrial loan delinquencies increased, while the total value of such loans dipped in the fourth ...
In a report released yesterday, Mike Mayo from Wells Fargo maintained a Buy rating on KeyCorp (KEY – Research Report), with a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results